Transforming Drug Delivery to the Eye
Short animation that shows how the Vitradel technology works

Drug delivery
Constant daily dose over a 6-12 month period

Functionalised Polymer
Tunable drug release, controlled biodegradation

In situ cross linking
Well-tolerated, safe implant with non-toxic by-products